Product image of Kanpiduo (Indapamide, Candesartan Cilexetil) supplied by GNH India

Kanpiduo

Active Ingredient:
Indapamide, Candesartan Cilexetil
Origin:
EU

Kanpiduo (Indapamide, Candesartan Cilexetil)

Indapamide and Candesartan cilexetil, the active ingredients in Kanpiduo, are a thiazide‑like diuretic and an angiotensin II receptor blocker presented as oral tablets for oral use. The combination provides complementary blood‑pressure reduction by promoting diuresis and blocking vasoconstriction, and it is prescribed to manage hypertension in adult patients.

GNH India supplies Kanpiduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Kanpiduo is used to treat hypertension, a condition characterized by elevated arterial pressure.
  • Essential hypertension: reduces systolic and diastolic blood pressure, helping lower cardiovascular risk.
  • Secondary hypertension: assists in blood‑pressure control when the elevation is caused by another underlying disorder.

How It Works

  • Indapamide acts on the distal convoluted tubule, inhibiting sodium‑chloride reabsorption and promoting water excretion. Candesartan cilexetil is a prodrug converted to candesartan, which selectively blocks AT1 receptors, preventing angiotensin II‑mediated vasoconstriction and aldosterone secretion. The combined effect produces additive reduction in peripheral vascular resistance and plasma volume, resulting in lowered blood pressure.

Side Effects

Kanpiduo may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: light‑headed sensation, especially after standing.
  • Headache: mild to moderate pain.
  • Fatigue: feeling of tiredness.
  • Electrolyte imbalance: low potassium or sodium levels.
  • Increased urination: more frequent need to void.

Serious or Rare Side Effects

  • Severe hypotension: marked drop in blood pressure causing fainting.
  • Renal impairment: worsening kidney function, indicated by rising creatinine.
  • Hyperkalemia: elevated potassium levels that may affect heart rhythm.
  • Angioedema: swelling of face, lips, or throat requiring emergency care.

Precautions & Warnings

When prescribing Kanpiduo, clinicians should consider several safety aspects.

  • Renal function: assess baseline kidney function and monitor during therapy.
  • Electrolytes: check serum potassium and sodium regularly.
  • Liver disease: use with caution in patients with hepatic impairment.
  • Concurrent diuretics: avoid excessive diuresis when combined with other diuretics.
  • Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited.
  • Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Avoid Interactions

Kanpiduo can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Potassium‑sparing diuretics: risk of hyperkalemia.
  • ACE inhibitors or other ARBs: additive blood‑pressure lowering, may cause hypotension.
  • Lithium: increased lithium levels, risk of toxicity.
  • NSAIDs: may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may enhance hypotensive effect.
  • Thiazide diuretics: increased risk of electrolyte disturbances.
  • Cyclosporine: may raise candesartan levels.
  • Alcohol: can augment dizziness and hypotension.

Frequently Asked Questions

Kanpiduo is an oral antihypertensive medication that combines a thiazide‑like diuretic with an angiotensin II receptor blocker. It is prescribed to lower elevated blood pressure in adults, helping to reduce the risk of cardiovascular events associated with hypertension.

Indapamide promotes diuresis by inhibiting sodium reabsorption in the distal tubule, reducing plasma volume. Candesartan cilexetil is converted to candesartan, which blocks AT1 receptors, preventing angiotensin II‑mediated vasoconstriction and aldosterone release. Together they lower peripheral resistance and fluid volume, resulting in blood‑pressure reduction.

The dose of Kanpiduo is individualized by the prescribing clinician based on the patient’s blood‑pressure profile, renal function, and other clinical factors. The prescriber determines the appropriate strength and dosing schedule.

Safety data for Kanpiduo in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing women.

To request Kanpiduo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Kanpiduo offers a dual mechanism—diuresis plus AT1‑receptor blockade—in a single tablet, which can simplify regimens compared with using separate diuretic and ARB products. This combination may provide more consistent blood‑pressure control while reducing pill burden.

Kanpiduo tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

Kanpiduo is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse events include severe hypotension, acute renal impairment, hyperkalemia, and angioedema. Patients should be monitored for sudden drops in blood pressure, changes in kidney function, elevated potassium levels, and any signs of swelling in the face or throat.

Kanpiduo is contraindicated in patients with known hypersensitivity to indapamide, candesartan, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, hyperkalemia, or those taking prohibited drug combinations such as other potassium‑sparing agents.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Indapamide, Candesartan Cilexetil

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT